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ABSTRACT
Background: Bovine mastitis, a serious disease associated with both high incidence and significant economic losses, 
posing a major challenge to the global dairy industry. The development of vaccines for protection from new infections by 
mastitis pathogens is of considerable interest to the milk production industry. Vaccination is a common and easy strategy 
for the control of infectious diseases, and the adjuvants used in the formulation is a critical factor for vaccine efficacy 
improvement. The main objective of the present study was to evaluate three different adjuvants for their ability to enhance 
immune responses of mice that vaccinated with Bovine Mastitis Multiple Vaccine.
Materials, Methods & Results: The thymus and spleen index, the phagocytic ability of macrophage and the serum antibody 
levels of mice were detected after vaccination, respectively. The results showed that the thymus index, spleen index, and 
the phagocytic ability of macrophage of mice in Aluminum group exhibited a significant higher level (P < 0.05) compared 
with those in the control groups. The difference of the serum antibody levels was significant (P < 0.05) between experi-
mental groups and control group after vaccination. The serum antibody concentration of mice in FIA group was higher 
compared with other groups and had a longer duration. The antibody concentration of mice in France 206 oil group can 
not increase as fast as the antibody concentration of Aluminum group, but it could last a longer time at a high level. In 
conclusion, multiple vaccines mixed with three different adjuvants (Aluminum, France 206 oil and Freund’s incomplete 
adjuvant) for bovine mastitis could enhance the immunity of mice and could decrease mortality of mice against challenge. 
Take all results from this work into consideration, Freund’s incomplete adjuvant (FIA) would be the best candidate as the 
adjuvant for mastitis multiple vaccines.
Discussion: The goal of vaccination is to generate strong immune response providing protection against infection for a time. 
Unlike attenuated live vaccines, killed whole organism or sub-unit vaccines generally require the addition of an adjuvant to 
be effective. What’s more, different protective effects will usually obtained by different adjuvants even use same antigen. 
Adjuvants play an important role in increasing the efficacy of a number of different vaccines. In this study, three kinds of 
adjuvants (Aluminum hydroxide, France 206 oil and FIA ) were evaluated for their adjuvant effects for multiple vaccine of 
bovine mastitis in mice and aluminum hydroxide did best as the vaccine adjuvant from the results. Aluminum hydroxide 
is a universally accepted adjuvant for both human and veterinary vaccines. The goal of vaccination is to generate strong 
immune response providing protection against infection for a time. Different protective effects will usually obtained by 
different adjuvants even use same antigen. In this work, FIA, Alum and 206 oil were chosen as adjuvants for inactivated 
antigens of Streptococcus agalactiae, Streptococcus dysgalactiae and Staphylococcus aureus. The results showed that 
there was a significantly higher antibody levels in vaccinated mice compared with those in control group. In addition, the 
mice in France 206 oil and FIA group performed a higher antibody levels and stronger immunity than mice in Aluminum 
hydroxide groups. These findings suggest that Freund’s incomplete adjuvant (FIA) would be the best candidate as the 
adjuvant for mastitis multiple vaccines investigated in this study.
Keywords: bovine mastitis, vaccine, adjuvant, immune response.
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INTRODUCTION
Bovine mastitis, a serious disease associated 
with both high incidence and significant economic losses 
[11,30], posing a major challenge to the global dairy in-
dustry [16]. When pathogenic microorganisms invade the 
mammary gland via the teat orifice and cause an inflam-
mation of the secretory tissue, manifesting itself in either 
clinical or sub-clinical mastitis [29]. Over 200 agents have 
been recorded to cause bovine mastitis [2], but the vast 
majority of cases were caused by Staphylococcus aureus, 
Streptococcus dysgalactiae, Streptococcus agalactiae, 
Escherichia coli and Streptococcus uberis [15,17,23].
Current practices to prevent and control mastitis 
based on diagnosis, segregation and the use of improved 
hygiene can contribute to a decrease in the occurrence 
of the disease [34]. However, such measures are often 
expensive and are not always practical or efficacious. 
Hence, the treatment for bovine mastitis still relies heav-
ily on the use of antibiotics [25]. Antibiotics are used 
extensively in food-producing animals to combat disease 
and to improve animal performance. In approximately 
80% of dairy farms in America, antibiotics are adminis-
trated routinely to entire herds to prevent mastitis during 
the dry-period. Beneficts of antibiotic use include lower 
incidence, reduced mortality, and more productive cows 
[22]. However, presence of antibiotic residues in milk 
is the greatest disadvantage of use of antibiotics for the 
treatment of mastitis, which is not only a public health 
issue but a severe economic loss for dairy farmers. In 
addition, use of antibiotics is largely responsible for the 
emergence of antimicrobial-resistant bacteria [6].
Due to these limitations of antibiotics, the de-
velopment of vaccines for protection from new infec-
tions by mastitis pathogens and reduce the need for the 
use of antibiotic is of considerable interest to the milk 
production industry. Vaccination is a common and easy 
strategy for the control of infectious diseases, and the 
adjuvants used in the formulation is a critical factor for 
vaccine efficacy improvement. The present study was 
designed to evaluate the immune responses of mice after 
immunisation with multiple vaccine composed of field 
isolates and a combination of three different adjuvants.
MATERIALS AND METHODS
Formulation of vaccine against bovine mastitis
Staphylococcus aureus (RFY84184), Strep-
tococcus agalactiae (RFY271) and S. dysgalactiae 
(RFY2531) used in this study were clinical bovine mas-
titis isolates which previously characterized as virulent 
strains and conserved in our laboratory. The bacteria 
were cultured by shaking at 37oC for 12 h in optimized 
Todd-Hewitt Broth (THB). The cells were harvested 
by centrifugation at 5000 g at 4oC for 10 min [18], and 
washed extensively in PBS before inactivation in 0.3% 
formalin for 18 h at 37oC [21]. Complete inactivation 
of the bacteria was confirmed by plating on blood agar 
plate for 48 h. Killed whole bacteria cells of S. aureus, 
S. agalactiae and S. dysgalactiae were mixed at 1:1:1 
and then was mixed with Freund’s incomplete adjuvant 
(FIA)1, Montanide ISA-206 (ISA-206)2 or Aluminium 
hydroxide (alum)3, respectively. Vaccines formulated 
with different adjuvants were stored at 4oC and can be 
used within 1 year.
Mice immunization
Three to four-week old Kunming mice (n = 264), 
purchased from Lanzhou University (Lanzhou, China), 
were used in the experiment. All animal procedures used 
in this study were approved by the Institutional Animal 
Care and Use Committee of Lanzhou University. Mice 
were randomly distributed into four groups with half 
male and half female, and subcutaneously vaccinated 
(day 0) and revaccinated (day 21) with 0.5 mL of vaccine 
with FIA (n = 64), ISA-206 (n = 64), or alum (n = 64). 
The rest of 64 mice were injected with 0.5 mL PBS by 
subcutaneous injection twice as control.
Assessment of phagocytic function of macrophages
Phagocytic function of macrophages of mice 
was evaluated by a previously reported method with 
some minor modification [33]. Eight mice were se-
lected randomly from each group at 35th, 50th, and 
65th day after first immunization, and 0.5 mL of 5% 
chicken-red blood cells (CRBC) were injected intra-
peritoneally into each mouse. After 12 h, the abdominal 
liquid of each mouse was collected and dropped on a 
slide, and fixed with a mixture of acetone/methanol 
(1:1, v/v) for 5 min, then stained with giemsa for 
3 min, rinsed with running water and dried. After 
drying, peritoneal macrophages were counted under 
microscope. The effect of vaccines on phagocytosis 
of macrophage was evaluated by the chicken-red cell 
phagocytic index, which were calculated using the 
following formulas: phagocytic index = the number 
of phagocytized CRBC / the number of macrophages 
which phagocytizing CRBC.
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Samples collection and detection of thymus and spleen 
indexes
Eight mice were selected randomly from each 
group at 21st , 35th, 50th ,and 65th day after first immuni-
zation. Blood of each mouse was collected and the serum 
samples obtained by centrifugation were kept frozen at 
-20oC. The entire spleen and thymus of mice were promptly 
removed after killed and weighed. The spleen and thymus 
indexes were calculated according to the formulas: (spleen 
or thymus weight / body weight) × 100% [23].
Determination of antibody levels by indirect EISA
Purified antigens were obtained by ultrasoni-
cation of S. aureus, S. agalactiae and S. dysgalactiae, 
and antigen concentrations were determined by Lowry 
method [10]. Ninety six-well plates were coated with 
100 μL of purified antigen in carbonate coating buffer 
at 37oC for 2 h, and then was transferred to 4oC, over-
night. The coated plates were washed three times with 
0.05% PBS-Tween 20, and the non specific binding was 
blocked by adding 120 μL per well of BSA-PBS and 
incubated at room temperature for 2 h. Then the coated 
plates were washed again, and 100 μL of each serum in 
PBS was added and incubated for 1 h at 37oC. Following 
washed with PBST, and incubated in goat anti-mouse 
Ig G HRP (Abcam, UK) diluted with PBS for 1 h at 
37oC. Then the plates were washed three times with 
PBS-Tween 20 and 100 μL of TMB per well was added 
and incubated for 10 min at RT. Finally, the enzymatic 
reaction was stopped by adding 50 μL 2M H2SO4 per 
well [5]. The optical densities were measured at 450 nm 
using a micro plate reader within 15 min [4,9].
Evaluation of protective effect of vaccines
Forty-five days after first vaccination, 10 mice 
from each group were challenged intravenously with 
0.1 mL zymotic fluid containing 108 CFU S. aureus. 
This strain was grown in Nutrient Broth (Oxoid, UK) 
for 12 h at 37oC and the bacterial concentration was 
determined by serial dilution on blood agar plates [24]. 
The mice were monitored daily for 14 days and the 
changes of the spirit, appetite and temperature were 
observed, and the death case was recorded.
Statistical analysis
Significant differences between groups were 
evaluated by using One-way ANOVA analysis in 
SPSS, and the difference was considered statistically 
significant when P < 0.05.
RESULTS
Effect of vaccines on phagocytic function of macrophages
To assess the influence of vaccines on phago-
cytic function of macrophages, eight mice of each 
group were injected intraperitoneally with CRBC at 
35th, 50th ,and 65th day after first immunization, and 
the phagocytic index of macrophages were calculated. 
As shown in Figure 1, compared with mice in control 
group, there is a higher level of phagocytic index of 
macrophages in vaccinated groups. One-way ANOVA 
analysis showed that there is a significant difference 
between Alum group and control group (P < 0.05), 
whereas the difference between ISA-206 group, FIA 
group and control group was not significant (P > 0.05) 
except for FIA group on 65th day after first vaccination.
Figure 1. Phagocytic index of mice in different groups over time. a-cDifferent 
letters indicate statistically significant differences (P < 0.05).
Effect of vaccines on thymus and spleen index
As shown in Figure 2, thymus and spleen index 
of mice in alum groups is higher than those mice in 
control groups (P < 0.05) on the 35th day after first 
vaccination. However there is no significant difference 
between ISA-206, FIA and control group (P > 0.05).
Antibody response in mice
ELISA results showed that as compared with 
control groups, higher levels of IgG in vaccinated groups 
were observed in 21st day after the first immunization 
(Figure 3). The highest levels of antibody in FIA and 
Alum groups were observed in 35th day after the first 
immunization, but antibody level of ISA 206 group was 
increased slowly. As shown in Figure 3, antibody titer 
decreased slowly with time after reached the highest 
point, which conform to change regularity of antibody.
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Figure 2. Thymus index (A) and spleen index (B) of mice in different groups over time. a-cDifferent letters indicate statistically 
significant differences (P < 0.05).
Figure 3. Specific serum antibody titer of Staphylococcus aureus (A), Streptococcus agalactiae (B) and S. dysgalactiae (C) 
in different roups over time.
Protection effect of vaccines against challenge
In order to compare the protective efficacy of 
vaccines with different adjuvants, 10 mice from each 
group were challenged via caudal vein with about 
1*108 CFU S. aureus per mouse on day 45 after prima-
ry immunization.The mortality of mice was observed 
and recorded during the first week post-challenge 
(Figure 4). These results indicate that vaccination 
conferred significantly higher (P < 0.05) protection 
as compared to control group. However, there was no 
distinctly difference between the three of vaccinated 
groups (P > 0.05).
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Figure 4. Survival curve of mice in different groups. a-cDifferent letters 
indicate statistically significant differences (P < 0.05).
DISCUSSION
Immune system is the major contributor to host 
defense against infection and maintaining heath, which 
consists of immune organs, immunocytes and immune 
molecules [19,32]. The thymus, one of the most impor-
tant immune organ, is the location of T-cell development 
where bone marrow-derived progenitors differentiate to 
become mature thymocytes before emigration into the 
periphery as new T cells [14]. The spleen, the largest pe-
ripheral immune organ, hosts major types of mononuclear 
phagocytes, including macrophages, DCs, and mono-
cytes, which are key protectors of the organism because 
they identify pathogensand cellular stress, remove dying 
cells and foreign material, regulate tissue homeostasis 
and inflammatory responses, and shape adaptive immu-
nity [3]. Thus, thymus, spleen and phagocytic index are 
important index reflecting the immune status.
In the present study, the results showed that 
macrophages collected from mice immunized with 
vaccine that aluminum hydroxide was used as adjuvant 
showed a higher activity, which represents an encour-
aging result compared to other groups, especially to 
control group (Figure 1). However, the promotion 
effect of vaccines on macrophages activity reduced 
gradually as time goes on. Vaccination enhanced the 
thymus and spleen index of mice, but the difference 
between vaccinated and control groups were not sig-
nificant except for mice in aluminum hydroxide group 
on 35th day after the first immunization (Figure 2).
Adjuvants play an important role in increasing 
the efficacy of a number of different vaccines [8]. In 
this study, three kinds of adjuvants (Aluminum hy-
droxide, France 206 oil and FIA ) were evaluated for 
their adjuvant effects for multiple vaccine of bovine 
mastitis in mice and aluminum hydroxide did best 
as the vaccine adjuvant from the results. Aluminum 
hydroxide is a universally accepted adjuvant for both 
human and veterinary vaccines [13]. Although it has 
been investigated since 1926, the exact mechanism by 
which aluminium hydroxide adjuvates vaccine antigens 
is unknown [31]. The proposed mechanisms of action 
of aluminum hydroxide include (1) formation of a 
depot allowing slow release of antigen, (2) adsorption 
of antigen onto micron-sized mineral particles that are 
avidly taken up by APCs, (3) stimulation of immuno-
reactive cells and (4) direct effects on macrophages 
[27]. Rimaniol et al. [28] had investigated the effect of 
aluminum hydroxide adjuvant on isolated macrophages 
in vitro, the results showed that aluminum hydroxide 
vaccine stimulated macrophages, and these mature 
antigen-presenting macrophages were particular im-
portance in the establishment of memory responses 
and in vaccination mechanisms leading to long-lasting 
protection. In another study, Lögdberg et al. [20] re-
ported that vaccination with the adhesin of candidal 
with aluminum hydroxide adjuvant reduced the tissue 
infectious burden of mice, and they also showed that 
the mechanism of protection was a Th1/Th17 response, 
resulting in recruitment and activation of phagocytes 
at sites of infection and more effective clearance of 
S. aureus and Candida albicans from tissues.
The goal of vaccination is to generate strong im-
mune response providing protection against infection for a 
time [1]. Unlike attenuated live vaccines, killed whole or-
ganism or sub-unit vaccines generally require the addition 
of an adjuvant to be effective [26]. What’s more, different 
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protective effects will usually obtained by different adju-
vants even use same antigen. In a previous study reported 
by Hu et al. [12], 18 heifers were randomly divided into 
three groups and were immunised twice intramuscularly 
with the S. aureus bacterin (control), or with the bacterin 
in combination with different adjuvants (crude ginseng 
extract and purified ginsenoside). The specific antibody 
response to S. aureus antigen was evaluated in blood 
samples taken before and after immunisations, and the 
results showed that crude ginseng extract had stronger 
adjuvant effects, when used for immunisation against 
S. aureus in dairy cattle. In this work, FIA, Alum and 206 
oil were chosen as adjuvants for inactivated antigens of 
Streptococcus agalactiae, Streptococcus dysgalactiae 
and Staphylococcus aureus. The results showed that there 
was a significantly higher antibody levels in vaccinated 
mice compared with those in control group. In addition, 
the mice in France 206 oil and FIA group performed a 
higher antibody levels and stronger immunity than mice 
in Aluminum hydroxide groups.
CONCLUSION
In conclusion, results from this investigation 
showed that: multiple vaccines mixed with three 
different adjuvants (Aluminum, France 206 oil and 
Freund’s incomplete adjuvant) for bovine mastitis 
could enhance the immunity of mice and could de-
crease mortality of mice against challenge; Take all 
results from this work into consideration, Freund’s 
incomplete adjuvant (FIA) would be the best can-
didate as the adjuvant for mastitis multiple vaccines 
investigated in this study.
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